Articles with "tdo2" as a keyword



Photo by shalone86 from unsplash

Development of a mass spectrometry-based tryptophan 2, 3-dioxygenase assay using liver cytosol from multiple species.

Sign Up to like & get
recommendations!
Published in 2018 at "Analytical biochemistry"

DOI: 10.1016/j.ab.2018.06.025

Abstract: A novel and rapid method to determine the potency of inhibitors for tryptophan 2, 3-dioxygenase (TDO2) activities in human and preclinical species was successfully developed and validated utilizing LC-MS/MS. Previously reported TDO2 activity assays are… read more here.

Keywords: tdo2; liver cytosol; development mass; multiple species ... See more keywords
Photo by little_klein from unsplash

Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.

Sign Up to like & get
recommendations!
Published in 2018 at "Trends in pharmacological sciences"

DOI: 10.1016/j.tips.2017.11.007

Abstract: Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase 2 (TDO2) catalyze the commitment step of the kynurenine (KYN) metabolic pathway. Traditionally the immunosuppressive effect of IDO1 has been attributed mainly to reduced levels of tryptophan, which… read more here.

Keywords: tdo2; tdo2 kyn; targeting ido1; cancer ... See more keywords
Photo by nci from unsplash

TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27

Sign Up to like & get
recommendations!
Published in 2021 at "BioMed Research International"

DOI: 10.1155/2021/4708439

Abstract: Background Tryptophan-2,3-dioxygenase (TDO2) converts tryptophan into kynurenine in the initial limiting step of the kynurenine pathway. During the past decade, the overexpression of TDO2 has been found in various human tumors. However, the role of… read more here.

Keywords: hepatocellular carcinoma; cell proliferation; tdo2; expression ... See more keywords
Photo by dawson2406 from unsplash

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy

Sign Up to like & get
recommendations!
Published in 2022 at "Disease Markers"

DOI: 10.1155/2022/5447017

Abstract: Background Tryptophan 2,3-dioxygenase (TDO) encoded by TDO2, a rate-limiting enzyme in the kynurenine pathway, catabolizes tryptophan to kynurenine, evades immune surveillance, and promotes tumor growth. Although accumulating evidence suggests a crucial role of TDO2 during… read more here.

Keywords: tdo2; prognosis; pancancer analysis; expression ... See more keywords

Synthetic Essentiality of Tryptophan 2,3-dioxygenase 2 in APC-Mutated Colorectal Cancer.

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer discovery"

DOI: 10.1158/2159-8290.cd-21-0680

Abstract: Inactivation of the adenomatous polyposis coli (APC) is common across many cancer types and serves as a critical initiating event in most sporadic colorectal cancers (CRC). APC-deficiency activates WNT signaling which remains an elusive target… read more here.

Keywords: tdo2; synthetic essentiality; cancer; tryptophan dioxygenase ... See more keywords

Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening

Sign Up to like & get
recommendations!
Published in 2019 at "Molecules"

DOI: 10.3390/molecules24234346

Abstract: Cancers express tryptophan catabolising enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2) to produce immunosuppressive tryptophan metabolites that undermine patients’ immune systems, leading to poor disease outcomes. Both enzymes are validated targets for cancer… read more here.

Keywords: ido1; tdo2; dioxygenase ido1; indoleamine dioxygenase ... See more keywords
Photo by nci from unsplash

TDO2 modulates liver cancer cell migration and invasion via the Wnt5a pathway.

Sign Up to like & get
recommendations!
Published in 2022 at "International journal of oncology"

DOI: 10.3892/ijo.2022.5362

Abstract: Liver cancer is a malignant cancer phenotype for which there currently remains a lack of reliable biomarkers and therapeutic targets for disease management. Tryptophan 2,3‑dioxygenase (TDO2), a heme‑containing polyoxygenase enzyme, is primarily expressed in cells of… read more here.

Keywords: tdo2; liver cancer; cancer cell; cell migration ... See more keywords